medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2017, Number 4

<< Back Next >>

Arch Med Fam 2017; 19 (4)

Preliminary Contributions and Proposal for a Reflection about the Medical Care Seminar I, II and III

Irigoyen CAE, Antunez CB, Jiménez SA

Language: Spanish
References: 56
Page: 149-154
PDF size: 188.12 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Fernández Ortega MA. Formación de especialistas en Medicina Familiar en México. 2014. Disponible en: http://www.observatoriorh.org/andino/sites/default/files/webfiles/dialogos/dgo_medfam/MiguelFernandez_mexico.pdf

  2. Bailón Muñoz E, de la Revilla Ahumada L. La atención familiar, la asignatura pendiente. Aten Primaria. 2011;43(2):55-57.

  3. De los Ríos Álvarez AM. Los procesos psicosociales. Características clínicas, factores individuales y familiares que se relacionan con su génesis. Tesis doctoral. Facultad de Medicina. Universidad de Granada, 1997. Citado por: Bailón Muñoz E, de la Revilla Ahumada L. La atención familiar, la asignatura pendiente. Aten Primaria. 2011;43(2):55-57

  4. Task Force Report 2. Report of the Task Force on Medical Education. Ann Fam Med March 1, 2004 vol. 2 no. suppl 1 S51-S64.

  5. The Future of Family Medicine: a collaborative project of the family medicine community. Ann Fam Med 2004;2 suppl:S1-S32. Available: www.annfammed.org/content/vol2/suppl_1/index.shtml.

  6. Revilla L de la, et al. Un nuevo enfoque de la enseñanza de la atención familiar en el programa de la especialidad de medicina familiar y comunitaria. Medicina de Familia (And) 2001; 2,(1):64-74.

  7. Ministerio de Educación, Cultura y Deporte de España. Programa de la Especialidad de Medicina Familiar y Comunitaria. Disponible en: http://www.scamfyc.org/documentos/PROGRAMA%20DE%20LA%20ESPECIALIDAD%20DE%20MEDICINA%20FAMILIAR%20Y%20COMUNITARIA%202004.pdf

  8. Pontificia Universidad Católica de Chile Escuela de Medicina Dirección de Postgrado. Disponible en: http://medicina.uc.cl/concursos/programa-postitulo-especialidades-y-sub-especialidades file:///C:/Users/SMF_vostro/Downloads/6-Programa-Medicina-Familiar-Mencion-Adulto%20(1).pdf

  9. Rodríguez Domínguez J, Fernández Ortega MA, Mazón JJ, Olvera F. La medicina familiar en México, 1954-2006. Antecedentes, situación actual y perspectivas. Aten Primaria. 2006;38(9):519-22.

  10. Ruiz Hernández B, Reyes Morales H, Estrada Obregón C, Sánchez López LF, Pedrote Navarro B, Vargas Alencaster LD, y cols. La medicina familiar en el Instituto Mexicano del Seguro Social: fortalezas y debilidades actuales. En: García Peña C, Muñoz O, Durán L, Vázquez F. La medicina familiar en los albores del siglo XXI. Instituto Mexicano del Seguro Social. México. 2006.p. 49.

  11. Plan único de especializaciones médicas (PUEM) en Medicina Familiar. México, D.F. UNAM. Plan de estudios aprobado por el Consejo Universitario el 21 de abril de 1994. Versión (2009)

  12. Muñoz-Hernández O, García-Peña MC, Vázquez-Estupiñán F. Perspectivas en medicina familiar. Arch Med Fam 2006; 8 (3):145-151. Disponible en: http://new.medigraphic.com/cgi-bin/resumen.cgi?IDARTICULO=11170.

  13. Meads G. Medicina Familiar: problemas y perspectivas del futuro. En: García Peña C, Muñoz O, Durán L, Vázquez F. La medicina familiar en los albores del siglo XXI. Instituto Mexicano del Seguro Social. México. 2006.p. 21-39.

  14. Narro Robles J, Mazón Ramírez J, Fernández Ortega M. La medicina familiar: sus bases evolución y desafíos. En: García Peña C, Muñoz O, Durán L, Vázquez F. La medicina familiar en los albores del siglo XXI. Instituto Mexicano del Seguro Social. México. 2006. p. 301-03. 154

  15. Michael A.Baker Asyntomatic Hyperuricemia Up Date Dec 11;2014

  16. Rajesh Mohandas et. Al. Uric Acid inhibition Dipeptidyl Peptidase IV in vitro is Dependent on the Intracellular Formation of Triurent. Experimental Cell Rersearch. 2014;326:136-142

  17. N. Babio et al. Uric Acid and Syndrome Metablic. Metabolism & Nutrition 2014:1-8

  18. Hopps E. et al. Behavior of the total antioxidant in a group of subjet with Metabolic syndrome. Diabetes & Metabolic Syndrome: Clinical Research and Reviews 2014;8:166-169

  19. Makovey J. Uric Acid and Rolen in Bone Low. Bone 2013:52:400-406

  20. Jisuk Bae et al. The Effect Vit C intake on the Risk Hyperucemia and Serum Uric Acid Level in Korean Multi-Rural community ies cohort. Joint bone Spine 2014;81:513-519.

  21. Erdim Sertoglu et al. The Relationship of Uric Acid With Non Alcoholic Fatty Liver disease. Clinical Biochemistry. 2014;47:383-388

  22. Lindsey A. Macfarlane. The Effect of Initiating Pharmacologic insulin on Serum Uric Acid Levels in Patients With Diabetes: a Matched Cohort Analysis. Seminars in Arthritis an Rheumatism. 2014:1-5

  23. David B. Mount. Update. Jan 16: 2014

  24. Sesti G. et al. Low circulating Insulin-Like Growth Factor-1 Leves are Associated With high Serum Uric Acid in non diabetic Adult Subjets. Nutrition Metabolism & Cardiovascular disease. 2014;24:1365-1372

  25. Zushang Zhu et al. High Uric Acid Directly Inhibits insulin signaling Induces insulin Resistance. Biochemicals and Biophysical Researchs communications. 2014;447:707-714

  26. Jong Suk Park et. Al. Relationships Between Serum Uric Acid Adiponectin and Stiffness in Postmenopausal Women. Maturitas. 2012;73:344-348

  27. Wei HS. High Uric Acid Levels is Associate with Higher rate of Metabolic Syndrome in Chinese Elderly. European Geriatrics Medicine. 2014;5:26-30

  28. Hyon K. Choi. Metabolic Syndrome Prevalence in Subjets whit Hypeuricemia. Am j Med. 2007;120:442-447.

  29. Anajas S. Cardoso. Association Uric Acid with Metabolic Syndrome Components. Journal Pediatrics (Rio J) 2013;84:412-418

  30. Ferrara LA. et. Al. Serum Uric Acid Does Not Predict Inciden Metabolic Syndrome in a Population With High Prevalence of Obesity. Nutrition Metabolism& Cardiovascular Disease 2014;24:1360-1364

  31. Duke- He Kang. Metabolism and The Kidney. Chapter 35. 2015: 418-427

  32. Liang WY. Uric Acid Promotes Chemokine and Adhesión molecule Production in Vascular Endotelium Via Nuclear Factor-Kappa B Signaling. Nutrition, Metabolism & Cardiovascular Disease. 2014;21:1-8

  33. Hayden M.R. New Look Uric Acid and Cardiovascular Disease, Diabetes Melltus and Metabolic Syndrome. Nutr Metab. 2014;10:1-15

  34. Malek P. Alopurinol Therapies on Mortality Patients With Cardiac Failure. J. Critical Care. 2012;27:e11-737 e24

  35. Zahotong Jia et al. Serum Uric Acid Levels and Incidence on Impaired Fasting Glucose and Type 2 Diabetes Mellitus: Meta-Analysis of Cohort Studies. Diab Res Clin Prac. 2013;101:88-96

  36. Vidula Bhole. Serum Uric Acid Levels and Risk of Type 2 Diabetes Mellitus: a Prospective Study. Am J Med. 2010;123:957-961

  37. Perticone F. Interaction Between Uric Acid and Endothelial Disfunction Predicts New Onset of Daibetes in Hypertensive Patients. Int J Cardiol. 2013;167:232-236

  38. Tanya Keenan et al. Relation of Uric Acid to Serum Levels of High Sensitivity-C Reactive Protein, Triglycerides and High Density Lipoprotein Cholesterol and to Hepatic Steatosis. Am J. Cardiol.2012;110:1787-1792

  39. Jung Yoon Choe. Association Between Uric Acid and Metabolic Syndrome. Quimica Clinica Acta. 2015;438:

  40. Soralla Civantos Modino. Hyperuricemia And Metabolic Syndrome in Children With Overweiht and Obesity. Endocrinol Nutr.2012;59:533-538

  41. Tamariz L. Et al. Association Uric Acid and Atrial Fibrilation. Heart Rhytm.2015

  42. Asiye Canbay. Uric Acid is a Potential Metiator of Cardiovascular Morbidity in Obstructive Sleep Apnea Syndrome. European Journa of Internal Medicine.2014;25;471-476

  43. Ko Chiu W. Significance and Association of Serum Uric Acid Levels With components of Metabolic Syndrome in the Elderly. Archives of Gerontology and Geriatrics. 2012;55:724-728

  44. Tracy D. Vannorsdall et al. Higher Baseline Serum Uric Acid is associated With Poorer cognition but not Rates of cognitive Decline in Women. Experimental Gerontology. 2014;60:136-139.

  45. Okadlec A. Kidney Stones. Urology. 2013;80):2013

  46. Nyebuck C. Roles of diets and dietary factors in the pathogenesis and prevention of anormal serum uric acid levels. 2015:3:29-45

  47. Sthepanie Nauyen. Sugar Weetened Beverages, Serum Uric Acid, and Blood Pressure in Adolecents. J. Pediatrics 2009:154;807-813

  48. Bose B. et al. Effect of Uric Acid-Lowering Therapy on Renal Outcomes: a Systematic review and Meta-Analysis. 2014;2:406-413

  49. El Bassossy H. Allopurinol Alleviates hypertension and Proteinuria in high Fructuose, high salt and high Fat, Induced –model of metabolic Syndrome. Traslation Research. 2015:1-10

  50. Oberback A. Bariatrics surgery in Severely Obese Adolescents Improves Major Coomorbidities Including Hyperglucemia. Metabolismo Clinical and Experimental. 63(2014):242-249

  51. Andersson C. Diferential Changes in SerumUric Acid Concentration in Sibutramine Promoted Weith Loss in Diabetes: Scout Trial. Nutrition & Metabolism. 2009;6:42

  52. Takagi H. Atorvastatin Therapy Reduced Serum Uric Acid Letter. International journal Cardiology. 2010;114:1-2

  53. Giorgini P. Metabolic syndrome and Uric Acid. Meeting european Metabolic síndrome. 2013

  54. Yu Wang Y. Predictive Value of Serum Uric Acid Levels for Daignosis of Metabolic Syndrome in Adolescents. The J. of Pediatrics. 2012;161:753-756

  55. Brudov Y. Effect of the Metabolic Syndrome and hyperuricemia on Outcome inPatients. With Coronary Artery Disease, (from the bezafibrate infarction prevenction study) Am J. Cardiol. 2010;106:1717-1720

  56. Verdogia M. Impact of diabetes on Uric Acid and its Relationship with the exent of coronary artery disease on platelet aggregation. Metabolism Clinical and Experimental. 63(2014):640-646




2020     |     www.medigraphic.com